Month: December 2018

OCNA Position Statment

The OCNA is committed to advocacy for the highest quality medication for all patients, especially the large immunocompromised population. Over the next few months, during the time of the implementation of the Laboratory testing regulations as per the Unity Plan, the OCNA will keep a database of Growers, Processors or dispensaries who are conducting Full Scale testing including Heavy Metals, Pesticides, Fungus and Mold. In addition to this information, we will collect information on which other dispensaries will be carrying fully tested product. This information will be posted on our website to assist patients to locate the highest quality medicine [...]

Read More